Coronavirus (COVID-19) Statement

We continue to closely monitor the situation surrounding the COVID-19 pandemic and are following the published recommendations of the CDC and the American Academy of Ophthalmology. We will continue to see our patients and treat any urgent/emergent needs.

With all of our offices open, the following protocols are in place:

1) We have greatly expanded measures to disinfect our office including cleaning between each patient appointment.

2) To limit any potential exposure, we ask you NOT to bring any non-essential person(s) with you to the appointment.

3) If someone must accompany you to your appointment, we ask that they do not enter the office, if at all possible.

4) If you have an upcoming appointment and identify with the following statements, please do not come directly to the office, but instead call us:

• Fever greater than 100.4

• Respiratory symptoms or difficulty breathing

• Exposed to someone with COVID-19 in the past 14 days

• Placed in self/hospital quarantine by medical doctor

 Your health and that of our staff is our guiding priority and we continue to update our protocol to ensure safety for everyone. If you have questions regarding these evolving protocols, please contact our office.

Retinal Conditions Exposed: Degenerative Myopia By Retina Associates, P.A. on September 11, 2015

An eye chart superimposed over an eyeAt Retina Associates, P.A., our experienced, highly trained physicians are able to diagnose and treat the full range of retinal conditions, including degenerative myopia. At our Kansas City area eye care practice, we have helped countless patients to improve and preserve their vision through timely identification of progressive retinal disorders and innovative, forward-thinking treatments. Degenerative myopia, also known as malignant or pathological myopia, is a relatively common condition, affecting roughly 2 percent of the population in the United States. Tragically, it is the seventh leading cause of legal blindness in the nation.

As with most eye disorders, early diagnosis and management of degenerative myopia are essential to preserving as much of a patient’s vision as possible. Given that approximately one-third of all cases of the disorder occur at birth, and most cases occur by the time a person reaches 13, it is important that parents are aware of the risk factors and symptoms associated with degenerative myopia. If your child is at risk for degenerative myopia, you should have his or her eyes routinely tested.

What is degenerative myopia?

Tens of millions of Americans are myopic, or nearsighted. Myopia refers to the condition by which people can focus clearly on nearby objects but cannot focus clearly on objects that are far away. For the vast majority of these people, myopia is a nuisance that can be remedied with eyeglasses, contact lenses, laser vision correction, or intraocular lenses (IOLs). For people with degenerative myopia, however, the problem is more complex.

Degenerative myopia places extreme stress on the retina, leading to a heightened risk of a variety of retinal and other vision problems. Loss of central vision, similar to that associated with age-related macular degeneration, is common. People with degenerative myopia are also at higher risk of retinal detachment, cataract formation, macula problems, and severe vision loss.

Risk Factors for Degenerative Myopia

In the United States, degenerative myopia is most common among people of Chinese, Japanese, Middle Eastern, and Jewish heritage. People at heightened risk for degenerative myopia also include those who were born with:

  • Down’s syndrome
  • Retinopathy of prematurity
  • Ocular albinism
  • Infantile glaucoma
  • Ehler’s-Danlos syndrome
  • Marfan’s syndrome
  • Low birth weight

Infants who were born to alcoholic mothers are also at risk for degenerative myopia.

Treatment of Degenerative Myopia

Currently, there is no way to prevent degenerative myopia; however there are ways to slow the progression of the condition and help to preserve vision. The most common method of treating degenerative myopia is a combination of photodynamic therapy and antiangiogenic drug therapy, similar to that used to treat age-related macular degeneration.

An oral medication called 7-methylxanthine has shown great promise in slowing the elongation of the eyeball among children aged 8 to 13 who have been diagnosed with degenerative myopia. Studies involving this medication may eventually point the way to an effective medical treatment for the condition.

Learn More about Degenerative Myopia

To learn more about degenerative myopia and its treatment, please contact Retina Associates, P.A. today.

Related to This

Retina Associates, PA logo

Retina Associates, LLC

Retina Associates, LLC is an advanced medical practice devoted to the diagnosis and treatment of retinal, macular, and vitreous diseases. Together, our eye care physicians belong to various prestigious organizations: 

  • American Board of Ophthalmology
  • American Academy of Ophthalmology
  • Association for Research in Vision and Ophthalmology
  • American College of Surgeons
  • American Society of Retina Specialists

Our mission is to help every patient preserve or restore their sight through our advanced treatment options. To discuss your needs with one of our doctors, request an appointment online or call us at (913) 831-7400.

Contact Us

Rate, Review & Explore

Social Accounts Sprite
Google map image of our location in 9301 W 74th St Ste 210 Shawnee Mission, KS

Shawnee Mission Office

9301 W 74th St
Ste 210
Shawnee Mission, KS 66204

Closed Today

What is the best time for you?

Add additional time

Tell us a bit about yourself...

(913) 831-7400 Send a message